{{Drugbox
| verifiedrevid = 437176178
| IUPAC_name = 2-(2-ethyl-2,3-dihydro-1-benzofuran-2-yl)-4,5-dihydro-1''H''-imidazole
| image = Efaroxan.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Uncontrolled
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 89197-32-0
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 72016
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 65015
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = G00490L21H
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 57895

<!--Chemical data-->
| C=13 | H=16 | N=2 | O=1 
| molecular_weight = 216.28 g/mol
| smiles = N\1=C(\NCC/1)C3(Oc2ccccc2C3)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H16N2O/c1-2-13(12-14-7-8-15-12)9-10-5-3-4-6-11(10)16-13/h3-6H,2,7-9H2,1H3,(H,14,15)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RATZLMXRALDSJW-UHFFFAOYSA-N
}}

'''Efaroxan''' is an [[alpha-2 adrenergic receptor|α<sub>2</sub>-adrenergic receptor]] [[receptor antagonist|antagonist]]<ref name="pmid9918591">{{cite journal |vauthors=Chopin P, Colpaert FC, Marien M |title=Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway |journal=J. Pharmacol. Exp. Ther. |volume=288 |issue=2 |pages=798–804 |date=February 1999 |pmid=9918591 |doi= |url=http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=9918591}}</ref> and [[receptor antagonist|antagonist]] of the [[imidazoline receptor]].

==See also==
* [[Fluparoxan]]
* [[Idazoxan]]

==References==
{{Reflist|2}}

{{Adrenergics}}
{{Imidazolinergics}}

[[Category:Benzofurans]]
[[Category:Imidazolines]]
[[Category:Alpha-2 blockers]]


{{drug-stub}}